📥 Input Dog Antibody Sequence
DNA or Amino Acid
Load Landmark Preset:
📊 Analysis Results
🐕
Enter a Canine nucleotide or amino acid sequence, or click a landmark preset above to begin.
📚 Canine Class I Functional Repertoire Catalog
Sourced from Stratum 3 Master Catalog (Cys104 Anchored)
| Gene ID | Locus | Chain | Classification | Mature V-Exon (to Cys104) | RSS / Evidence | Action |
|---|
🔬 Benchmark Caninized Monoclonal Antibodies
Approved Veterinary Biotherapeutics
| Clone / Therapeutic | Clinical Target | V / J Assignment | Boundary | Therapeutic Mechanism & Significance | Action |
|---|
🏛️ Caninization Engineering & Comparative Immunogenetics
Companion Animal Antibody Architecture
The Veterinary Monoclonal Antibody Revolution:
Companion animal therapeutics has undergone a rapid paradigm shift with the advent of "caninized" monoclonal antibodies. Rather than using small molecules with non-specific organ toxicity, veterinary medicine now utilizes high-affinity caninized antibodies engineered to match the natural canine immunoglobulin architecture.
Key Structural & Immunogenetic Hallmarks in VBASE3:
- Inverted Light Chain Partitioning (~90% Lambda Dominance): Whereas humans exhibit ~60% Kappa and mice >95% Kappa, dogs display an inverted repertoire dominated by the Lambda light chain (~90% IGL vs. ~10% IGK). Therapeutic caninization campaigns must account for this structural preference when selecting light chain pairings.
- Restricted Heavy Chain Families: The canine heavy chain repertoire is predominantly composed of Clan III-related IGHV genes that exhibit high homology to human IGHV3, greatly simplifying human-to-canine antibody conversion.
- Strict IMGT Synthesis Boundaries: Canonical synthesis endpoints (
TVSSfor heavy,TVLfor lambda, andVEIK/LEIKfor kappa) ensure zero constant region bleed-through in recombinant veterinary production. - Repertoire-Confirmed Class I Functional Universe: All 29 canine V-genes in this analyzer represent confirmed functional segments with rearranged physiological evidence, trimmed strictly to Cys104.